Ascentage Pharma Group International (AAPG) Total Current Liabilities (2023 - 2025)

Ascentage Pharma Group International (AAPG) has 3 years of Total Current Liabilities data on file, last reported at $231.7 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 42.67% year-over-year to $231.7 million; the trailing twelve-month figure through Dec 2025 stood at $231.7 million (up 42.67% YoY), and the FY2025 full-year result was $235.0 million, up 47.04% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $231.7 million, up from $173.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $231.7 million in Q4 2025 and bottomed at $129.7 million in Q4 2023.
• The 3-year median for Total Current Liabilities is $167.7 million (2024), against an average of $174.2 million.
• The widest annual swing landed in 2024, when Total Current Liabilities rose 25.18%; it then jumped 42.67% in 2025.
• A 3-year view of Total Current Liabilities shows it stood at $129.7 million in 2023, then grew by 25.18% to $162.4 million in 2024, then surged by 42.67% to $231.7 million in 2025.
• The last three Total Current Liabilities figures came in at $231.7 million (Q4 2025), $173.0 million (Q2 2025), and $162.4 million (Q4 2024), per Business Quant data.

Peer Comparison